Evidence map›Paper›PMID 42180854›Full record

ArticleTranslational cancer research2026

Digitoxin inhibits the growth of HSC-3 cells by inducing G2/M cell cycle arrest and apoptosis.

Ying Rui, Yan Wang, Hongfei Gong, Xuanyu Zhu, Qing Xu, Jing Lin, Jingchen Wei

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying Rui *School of Pharmacy, Guilin Medical University, Guilin, China.ORCID https://orcid.org/0000-0002-1689-9204
Yan Wang *People's Hospital of Guilin, Guilin, China.
Hongfei GongSchool of Pharmacy, Guilin Medical University, Guilin, China.
Xuanyu ZhuSchool of Pharmacy, Guilin Medical University, Guilin, China.ORCID https://orcid.org/0000-0002-1763-5251
Qing XuSchool of Pharmacy, Guilin Medical University, Guilin, China.
Jing LinDepartment of Oncology, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Jingchen WeiSchool of Pharmacy, Guilin Medical University, Guilin, China.ORCID https://orcid.org/0000-0002-5117-8832

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral squamous cell carcinoma (OSCC) remains a substantial global health burden. According to the latest global cancer statistics, it accounts for an estimated 300,000 new cases and 100,000 deaths annually. This study aimed to investigate the pharmacological effects of digitoxin, a cardenolide glycoside, on the modulation of proliferative capacity and apoptotic induction in human OSCC human tongue squamous carcinoma (HSC-3) cells. Methods: Results: Digitoxin treatment reduced the viability of HSC-3 cells in a concentration-dependent manner and concurrently increased the apoptotic fraction. Mechanistically, digitoxin induced G Conclusions: Digitoxin inhibited the growth of HSC-3 cells both

Indexed as

apoptosiscell cycleDigitoxinHSC-3 cells

Identifiers

PMID42180854
PMCPMC13190828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.